Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters

Pediatric Infectious Disease Journal

Volumn 19, Issue 5 SUPPL., 2000, Pages

  Jacobs, Michael R ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Antibiotics; Otitis media; Pathogens; Pharmacodynamics

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; LORACARBEF;

AGE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; CONFERENCE PAPER; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0034124275     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200005001-00008     Document Type: Conference Paper

References (29)

1. Dowell SF, Butler JC, Giebink GS, and the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9.
2. Jacobs MR, Dagan R, Appelbaum PC, Burch D. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998;42:589-95.
3. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved Standard NCCLS Document M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, 1995.
4. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10.
5. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9.
6. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
7. Dagan R, Johnson CE, McLinn S. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000;19:95-104.
8. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992;15:119-27.
9. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15: 255-9.
10. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
11. Jacobs MR, Appelbaum PC. Antibiotic-resistant pneumococci. Rev Med Microbiol 1995;6:77-93.
12. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977;2:995-7.
13. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiple resistant pneumococci. N Engl J Med 1978;299:735-40.
14. Jacobs MR, Bajaksouzian S, Palavecino-Fasola EL, Appelbaum PC, Holoszyc H. Penicillin MICs of Streptococcus pneumoniae determined using penicillin, oxacillin and methicillin disks. J Clin Microbiol 1998;36:179-83.
15. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U. S. surveillance study. Antimicrob Agents Chemother 1999;43:1901-8.
16. Jacobs MR. Assessing the quality of the Alexander Project. J Chemother 1999;11:26-34.
17. Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity ampicillin, amoxicillin, amoxicillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995;35:883-8.
18. Ronchetti MP, Zilles A, Appelbaum PC, Jacobs MR. Susceptibility of current and archived otitis media isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to contemporary oral agents [Abstract E-9]. In: Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology; 1998.
19. Fasola EL, Bajaksouzian S, Appelbaum PC, Jacobs MR. Variation in erythromycin and clindamycin susceptibility testing of Streptococcus pneumoniae with four test methods. Antimicrob Agents Chemother 1997;41:129-34.
20. Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob Agents Chemother 1994;38:2902-4.
21. Roger G, Carles P, Pagnon B, et al. Management of acute otitis media caused by resistant pneumococci in infants. Pediatr Infect Dis J 1998;17:631-8.
22. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US Medical Centers in 1992 and 1993. Antimicrob Agents Chemother 1994;38:2419-25.
23. Jones RN, Jacobs MR, Washington JA, Pfaller MA. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents: a 187 clinical laboratory center sample in the United States. Diagn Microbiol Infect Dis 1997;27:75-84.
24. Rittenhouse SF, Miller LA, Kaplan RL, Mosely GH, Poupard JA. A survey of beta-lactamase-producing Haemophilus influenzae: an evaluation of 5750 isolates. Diagn Microbiol Infect Dis 1995;21:223-75.
25. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
26. Paradise JL. Antimicrobial drugs and surgical procedures in the prevention of otitis media. Pediatr Infect Dis J 1989;8: S35-7.
27. Dagan R, Piglansky L, Fliss DM, Leiberman A, Leibovitz E. Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor, and amoxicillin [Abstract K103]. In: Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1997.
28. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Ninth Informational Supplement. M100-S9. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
29. Pankuch GA, Jueneman SA, Davies TA, Jacobs MR, Appelbaum PC. In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2914-8.